Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin-Reference-Cited by-同舟云学术

Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin

Published:2018-05 Issue: Volume:139 Page:67-80
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Abdelwahed O.M.,Tork O.M.,Gamal el Din M.M.,Rashed L.,Zickri M.

Funder

Cairo University

Publisher

Elsevier BV

Subject

General Neuroscience

Reference97 articles.

1. Effect of C-peptide on cognitive dysfunction in type 1 diabetic rat;Abedinzadeh;J. Guilan Univ. Med. Sci.,2009

2. Alzheimer’s disease, ceramide, visfatin and NAD;Adams;CNS Neurol. Disord. Drug Targets,2008

3. Neuroprotective effects of eexenatide in a rotenone-induced rat model of Parkinson’s disease;Aksoy;Am. J. Med. Sci.,2017

4. Effect of diabetes mellitus on rat cognitive functions and related hippocampal synaptic plasticity markers;Amin;Med. J. Cairo Univ.,2011

5. Deterioration of spatial learning performances in lipopolysaccharide-treated mice;Arai;Jpn. J. Pharmacol.,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exendin‐4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease;Chemical Biology & Drug Design;2023-12-15

2. Intranasal Exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: Role of mTORC1 in immunogenic and tolerogenic cell demise;European Journal of Pharmacology;2023-12

3. Long-term treatment with roflumilast improves learning of fear extinction memory and anxiety-like response in a type-1 diabetes mellitus animal model;Behavioural Brain Research;2023-02

4. GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes;Diabetologia;2022-06-10

5. Targeting NRF2 in Type 2 diabetes mellitus and depression: Efficacy of natural and synthetic compounds;European Journal of Pharmacology;2022-06